Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12530/21345
Title: | Antioxidants in Translational Medicine. | |
Authors: | ||
Mesh: | ||
Issue Date: | 10-Nov-2015 | |
Citation: | Antioxid. Redox Signal..2015 Nov;(23)14:1130-43 | |
Abstract: | It is generally accepted that reactive oxygen species (ROS) scavenging molecules or antioxidants exert health-promoting effects and thus their consumption as food additives and nutraceuticals has been greatly encouraged. Antioxidants may be beneficial in situations of subclinical deficiency and increased demand or acutely upon high-dose infusion. However, to date, there is little clinical evidence for the long-term benefit of most antioxidants. Alarmingly, recent evidence points even to health risks, in particular for supplements of lipophilic antioxidants. | |
PMID: | 26154592 | |
URI: | https://hdl.handle.net/20.500.12530/21345 | |
Rights: | openAccess | |
Appears in Collections: | Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos | |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PMC4657516.pdf | 663.32 kB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.